- Investing Ideas
- Egyptian Pharmaceuticals & Biotech Sustainable Track Record
Egyptian Pharmaceuticals & Biotech Sustainable Track Record
Results
5
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
5 companies
Arab Drug
Market Cap: ج.م3.5b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م292.35
7D
2.9%
1Y
76.7%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.4b
Operates as a pharmaceutical company in Egypt.
AXPH
ج.م1,687.50
7D
24.1%
1Y
160.1%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م9.2b
Engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م402.54
7D
7.7%
1Y
191.6%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م18.6b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م372.30
7D
9.5%
1Y
574.5%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.1b
Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally.
CPCI
ج.م544.16
7D
3.1%
1Y
152.0%